These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 9780230)
1. Phorbol ester causes ligand-independent activation of the androgen receptor. Darne C; Veyssiere G; Jean C Eur J Biochem; 1998 Sep; 256(3):541-9. PubMed ID: 9780230 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Ikonen T; Palvimo JJ; Kallio PJ; Reinikainen P; Jänne OA Endocrinology; 1994 Oct; 135(4):1359-66. PubMed ID: 7925097 [TBL] [Abstract][Full Text] [Related]
3. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening. Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975 [TBL] [Abstract][Full Text] [Related]
4. Interaction of antiandrogen-androgen receptor complexes with DNA and transcription activation. Warriar N; Pagé N; Koutsilieris M; Govindan MV J Steroid Biochem Mol Biol; 1993 Dec; 46(6):699-711. PubMed ID: 8274404 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase C pathway potentiates androgen-mediated gene expression of the mouse vas deferens specific aldose reductase-like protein (MVDP). Fabre S; Darne C; Veyssière G; Jean C Mol Cell Endocrinol; 1996 Nov; 124(1-2):79-86. PubMed ID: 9027327 [TBL] [Abstract][Full Text] [Related]
6. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP. Warriar N; Pagé N; Koutsilieris M; Govindan MV Prostate; 1994 Apr; 24(4):176-86. PubMed ID: 8146066 [TBL] [Abstract][Full Text] [Related]
7. Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat. Vacca A; Screpanti I; Maroder M; Petrangeli E; Frati L; Gulino A Mol Endocrinol; 1989 Oct; 3(10):1659-65. PubMed ID: 2558300 [TBL] [Abstract][Full Text] [Related]
8. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189 [TBL] [Abstract][Full Text] [Related]
9. Modulation of androgen receptor transcriptional activity by the estrogen receptor. Kumar MV; Leo ME; Tindall DJ J Androl; 1994; 15(6):534-42. PubMed ID: 7721655 [TBL] [Abstract][Full Text] [Related]
10. Effects of mitogens on androgen receptor-mediated transactivation. Reinikainen P; Palvimo JJ; Jänne OA Endocrinology; 1996 Oct; 137(10):4351-7. PubMed ID: 8828495 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the promoter of the gene for a mouse vas deferens protein related to the aldo-keto reductase superfamily: effect of steroid hormones and phorbol esters. Fabre S; Darne C; Veyssiere G; Jean C J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):315-25. PubMed ID: 8541228 [TBL] [Abstract][Full Text] [Related]
12. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription. Yen PM; Liu Y; Palvimo JJ; Trifiro M; Whang J; Pinsky L; Jänne OA; Chin WW Mol Endocrinol; 1997 Feb; 11(2):162-71. PubMed ID: 9013763 [TBL] [Abstract][Full Text] [Related]
13. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell. Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129 [TBL] [Abstract][Full Text] [Related]
14. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor. Govindan MV Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476 [TBL] [Abstract][Full Text] [Related]
15. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor. List HJ; Lozano C; Lu J; Danielsen M; Wellstein A; Riegel AT Exp Cell Res; 1999 Aug; 250(2):414-22. PubMed ID: 10413595 [TBL] [Abstract][Full Text] [Related]
16. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959 [TBL] [Abstract][Full Text] [Related]
17. Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. Sato N; Sadar MD; Bruchovsky N; Saatcioglu F; Rennie PS; Sato S; Lange PH; Gleave ME J Biol Chem; 1997 Jul; 272(28):17485-94. PubMed ID: 9211894 [TBL] [Abstract][Full Text] [Related]
18. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364 [TBL] [Abstract][Full Text] [Related]
19. The amino terminus of the human AR is target for corepressor action and antihormone agonism. Dotzlaw H; Moehren U; Mink S; Cato AC; Iñiguez Lluhí JA; Baniahmad A Mol Endocrinol; 2002 Apr; 16(4):661-73. PubMed ID: 11923464 [TBL] [Abstract][Full Text] [Related]
20. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]